
Obravnava novoodkritih bolnikov z miastenijo gravis v regionalni bolnišnici med leti 2003–2013
Author(s) -
Mateja Baruca,
Anton Grad
Publication year - 2017
Publication title -
zdravniški vestnik
Language(s) - English
Resource type - Journals
eISSN - 1581-0224
pISSN - 1318-0347
DOI - 10.6016/zdravvestn.1937
Subject(s) - medicine , myasthenia gravis , pediatrics , thymectomy , incidence (geometry) , population , disease , graves' disease , ocular myasthenia , physics , environmental health , optics
Background: Myasthenia gravis (MG) is the most common autoimmune disorders of the neuromuscular junction. Advances in intensive care in conjunction with the advent of novel treatments have made MG one of the most treatable neurological disorders. The incidence and prevalence rates of MG have increased over time due to greater disease awareness, better diagnostic methods and ageing of the population. Due to these facts, the number of MG patients evaluated at the secondarylevel regional hospitals has increased. So far, no data on the evaluation of MG in Slovenia have been systematically collected. The aim and scope of this article is to present the analysis of the evaluation of newly diagnosed MG patients at the General hospital of Isola for the time period between 1 January 2003 and 31 December 2013.Methods: We reviewed medical files of MG patients diagnosed at the General hospital of Isola in the above mentioned time period and collected data on patients’ demographic and clinical characteristics in addition to examining their clinical course and treatment outcome.Results: Twenty-nine patients were identified (14 women, 15 men). Te mean age at disease onset was 59.4 ± 21.2 years for women and 56.3 ± 19.8 years for men. In the study population, 58.6 % of the patients were acetylcholine receptor antibody positive. Besides MG, patients most often had thyroid and other chronic diseases. Most patients (68.9 %) presented with extraocular disease symptoms, which progressed to generalized disease in 65 % of cases. Myasthenic crisis occurred in 10.3 % of patients. In 68.9 % of cases, the patients were treated exclusively with symptomatic therapy. Tymectomy was performed in 13.7 % of cases. On treatment, 13.7 % achieved a stable complete remission of MG symptoms, in 55 % the condition substantially improved, in 20.6 % improvement was only partial, and in 6.8 % of patients the condition remained unchanged. The fiveyear mortality of the study population, estimated according to the Kaplan-Meier method was 13.5 %.Conclusions: With the exception of a higher mortality rate, the patients’ characteristics and clinical course of the disease were similar to data reported in other epidemiological studies. The patients’ higher mortality rate was considered to be a consequence of the lack of intensive treatment in patients with myasthenic crisis due to the unawareness of the reversibility of the condition with an adequate treatment.